The purpose of this prospective study was to evaluate the outcomes of coccygectomy for patients with chronic coccydynia.
When conservative treatment for chronic coccydynia has failed, coccygectomy may be considered, and favourable outcomes have been reported. [5] [6] [7] [8] [9] [10] However, there is bias amongst orthopaedic surgeons, who dispute its effectiveness.
In this paper, we have evaluated the outcomes of the surgical management of patients with chronic coccydynia. We hypothesised that most patients with this condition would have objective improvement following total coccygectomy.
Patients and Methods
This is a prospective observational case series of patients who underwent total coccygectomy for chronic coccydinia. Patients. Between September 2007 and August 2011, 317 patients with a diagnosis of coccydynia (ICD-9 code 724.79) were evaluated by the senior author (ENH) and screened for inclusion in the study. Patients were eligible for inclusion if they were aged > 18 years, had pain in the region of the coccyx and tenderness on examination, had persistent severe symptoms despite conservative treatment (including non-steroidal anti-inflammatory drugs (NSAIDs) or at least one sacrococcygeal injection) and had radiographic evidence of coccygeal abnormality as described by Maigne et al. [11] [12] [13] As standard practice, all patients were offered the option of sacrococcygeal injection before consideration of coccygectomy. Patients with concomitant spinal disorders were included if there was no evidence that the spinal pathology was the cause of coccygeal pain. The study had ethical approval and all patients gave informed consent. Surgical procedure. All operations were performed by the senior author (ENH) using the same technique. With the patient in the prone position, a midline longitudinal incision 5 cm in length was made in sacrococcygeal area. Electrocautery was used to expose the distal sacrum and coccyx subperiosteally. The entire coccyx was then removed. Fibrous tissue was left on the distal aspect of the sacrum in order to minimise the formation of ectopic bone. The wound was irrigated using pulsatile lavage with Bacitracin 50 000 units in 3L of normal saline solution. Haemostasis was achieved and the fascia and subcutaneous tissue were closed in two separate layers using interrupted number 1 and 2/0 Vicryl sutures, respectively. The skin was closed with interrupted 2/0 nylon sutures. The wound was covered with a waterproof adhesive dressing containing 1.2% ionic silver (Aquacel Ag, Skillman, New Jersey). All patients received an intravenous weight-based dose of Cefazolin peri-operatively and oral Sulfamethoxazole-Trimethoprim (800 mg-160 mg) and Cephalexin (500 mg) for five days post-operatively. No prophylaxis for venous thromboembolism was used. Post-operative care. Patients were instructed to rest but not to sit for three weeks after surgery, at which time the sutures were removed. No lifting greater than 10 lbs. was allowed for three months. Outcome measures and follow-up. The following details were recorded for each patient: age, body mass index (BMI), symptoms, treatment prior to surgery, and comorbid conditions including spinal pathology, and postoperative complications. The questionnaire included the Short Form 36 (SF-36), Oswestry Disability Index v2 (ODI), and the visual analogue scale pain indicator (VAS-PI). The SF-36 is a generic measure of health-related quality of life (HRQoL) that has validated use across several populations, including spine patients. 14, 15 The VAS-PI, a widely used and reliable measure of pain, uses a physical range of 100 mm for determining pain intensity, ranging from zero (no pain) to 100 (very severe pain). 16, 17 The ODI, designed to assess limitations of various activities of daily living (ADL), is the most commonly used condition-specific measure for spinal disorders and has a proven record of validity, Potential participants assessed for eligibility (n = 115) Excluded -ineligible (refused surgery) n = 15
Eligible for study (n = 100) Excluded -protocol violation (consent after surgery) n = 2
Consented to participate (n = 98)
Losses to follow-up: n = 4
Completed 2-yr follow-up (n = 94) Clinical flow diagram reliability and responsivity. The index is scored from zero (no disability) to 100% (complete disability), with a score of 22 or higher considered an indication of significant ADL disability. 18, 19 Secondary subgroup analysis compared the outcomes and characteristics of patients with a successful outcome following coccygectomy with those whose treatment had failed. The threshold for successful treatment was based on a minimum clinically importance difference (MCID) of 20 points on the ODI at two years' follow-up and an overall ODI score of < 22 points. 18, 19 Patients who did not meet this threshold or were lost to follow-up were classified as failure of treatment. Statistical analysis. Descriptive statistics were calculated for all patient characteristic variables. The SF-36, ODI, VAS score were calculated for each patient. Repeated measures analysis of variance using generalised estimating equations (GEE) was used to compare three time points for the SF-36, ODI and VAS scores to account for correlated data. Statistical significance was set at p = < 0.05.
Results
A total of 115 patients with chronic coccydynia met the inclusion criteria and were treated surgically; 15 declined to enter the study and two patients who consented to enrollment after surgery were excluded. Thus 98 patients (87 women and 11 men) were included. Data were available for 84 patients at one year and 94 patients at two years post-operatively. Four patients were lost to follow-up. All outcome analyses were based on the 94 patients available two years post-operatively (Fig. 1) . Patient characteristics. The demographic details of the patients are summarised in Table I . The mean duration of symptoms was five years (three months to 50 years). A total of 89 patients (90.8%) had symptoms for > one year. Most (71.4%) had received a steroid injection prior to surgery and 45 (45.9%) took opiates for pain management. Among the 28 patients (28.4%) who refused steroid injections, the mean duration of symptoms was 6.9 years (one to 50). Three patients had symptoms for six months and had failed steroid injection therapy prior to coccygectomy. A total of 28 patients (28.6%) had a chronic pain syndrome with associated migraine, fibromyalgia or a genitourinary pain disorder.
Clinical outcomes. Table II shows the outcomes one and two years post-operatively. There were significant improvements in all ten components of the SF-36v2 (p < 0.05). The success of treatment. A total of 69 patients (70.4%) met the designated MCID threshold for a successful outcome. The remaining 29 patients were classified as failures of treatment: 25 (25.5%) had ODI scores that did not meet the MCID threshold and (4.1%) were lost to follow-up. Six patients (6.1%) classified as failures, had ODI scores that were no better or worse than the baseline. Two of the four patients lost to follow-up expressed dissatisfaction with the outcome at their last recorded visit and were included in the failure group, as it was assumed that an unsatisfactory outcome was the reason for loss to follow-up.
Comparisons of the characteristics and clinical outcomes of both groups are outlined in Tables III and IV . There was no significant difference in age, BMI, or comorbid conditions between the two groups. There was a significantly higher incidence of psychiatric disorders and opiate use prior to surgery, and a lower incidence of migraine, in the failure group. There was no significant difference between the groups in the rates of prior injection therapy, lumbar spinal pathology, non-spinal musculoskeletal pathology, genitourinary pain disorders or chronic pain syndrome. There was no significant difference in outcome for patients with less than three comorbid conditions. However, those with more than three comorbid conditions had a higher incidence of failed treatment.
Compared with the group in whom treatment was successful, the mean pre-operative ODI and VAS scores were significantly worse in those in whom treatment failed. The latter group also had significantly worse pre-operative SF-36 physical function, role functioning-physical, pain and general health scores. There was no significant difference in the pre-operative SF-36 Role functioning-emotional, energy/ fatigue, emotional wellbeing, social functioning and health change scores. There was a mean clinical improvement in ODI score of 27.92 points in the success group, compared with 6.04 points in the failure group (p < 0.0001), two years post-operatively (Fig. 2 ). There was a mean improvement in the VAS score of 45.73 points in the success group compared with 18.92 points in the failure group (p < 0.0001). The failure group also had significantly less improvement in all SF-36 categories except social functioning (p < 0.05). Complications. A total of 12 patients (12.2%) had postoperative complications requiring further surgery; 11(11.2%) had wound dehiscence requiring debridement. Five of these patients (5.1%) had local infection requiring irrigation and debridement and antibiotic treatment ( Table V) . The remaining six (5.5%) had wound dehiscence alone without infection. Four of the five patients with a post-operative infection had a successful outcome two years post-operatively. The fifth had an early post-operative infection, which resolved with treatment but had a delayed wound dehiscence more than one year later. This patient developed a chronic sacral wound requiring excision and skin graft with a persistent but healing wound at the last visit. This patient had Sjogren's syndrome requiring immunosuppressive treatment at the time of the wound dehiscence. One patient (1.0%) required further surgery to excise a residual first coccygeal segment. An additional eight patients (8.2%) had minor delayed wound healing requiring topical wound care only. These wounds healed rapidly. The incidence of complications, wound dehiscence, infection or minor delayed wound healing did not differ significantly between the groups (Table II) .
Discussion
This is the largest prospective study evaluating coccygectomy for the treatment of chronic coccydynia. We found that this procedure resulted in significant improvement in function, disability-related outcomes, QoL and pain two years post-operatively for most patients. To date, there is no established threshold for the MCID of any clinical outcome measures used following coccygectomy. Previous prospective studies evaluating coccygectomy have reported good or excellent outcomes ranging from 68% to 92% in studies with 28 to 37 subjects. 12, [20] [21] [22] However, objective outcome measures were rarely used and the criteria for 'good' or 'excellent' were often based solely on clinical judgment. A distribution-based MCID may be determined by using a one half standard deviation benchmark to quantify a moderate effect size. In this study, a post hoc calculation of the distribution-based MCID for the ODI for the group with a successful outcome at two years would be 5.77. This threshold was not felt to be rigorous enough to be clinically relevant. In the recent literature dealing with surgery to the lumbar spine, distribution-based MCID calculations for the ODI have ranged from 6.8 points for extension of fusion for adjacent segment disease 23 to 14.9 points for transforaminal lumbar interbody fusion for degenerative spondylolisthesis. 24 One study has suggested a threshold for minimally acceptable outcomes of 20 points in the ODI for spinal fusion, 19 which is nearly four times the MCID in our study. This 20-point difference with an overall ODI score of < 22 points provided us the most rigorous benchmark for improvement. The operation was deemed to be successful in 70.4% of patients using these criteria. In order to validate the clinical relevance of our threshold, we compared the outcomes of our 'success' and 'failure' groups. Patients classified as 'successes' based on the ODI score threshold also had VAS-PI scores and SF-36 scores that were significantly better than the 'failure' group. Previous studies evaluating low back pain and sciatica have suggested that VAS-PI improvement to a score of < 30 (of 100) best discriminates between patients in whom treatment is successful with recovery or significant improvement, or not. 16 The mean VAS scores for our 'success' and 'failure' groups were 10.01 and 48.6 post-operatively, respectively. A recent systematic review of responsiveness of patient-reported outcome measures (PROMS) for pain, function and HRQoL in lumbar spinal surgery, reported that VAS pain and ODI were the measures that were the most treatment specific and the most responsive to change post-operatively. 25 This further supports the 20-point change and < 22 point total score in ODI as a clinically important measure of the success of treatment in patients who undergo coccygectomy.
The indications for coccygectomy are difficult to define as the cause of coccydynia in many patients is unknown. Neurosis and/or psychiatric disorders have often been associated with coccydynia or thought to be a contributing or magnifying factor. 13, 26, 27 Several authors have also postulated that if there was a psychogenic aetiology for coccydynia, it may contribute to poorer outcomes following surgical treatment. 7, 28, 29 However, many patients with spinal symptoms also have psychiatric disorders. In a series of 200 patients, Polatin et al 30 reported that 59% with low back pain had evidence of a psychiatric disorder, which is higher than our rate of 45.9% in patients with coccydynia. Furthermore, while psychiatric disorders are a well-known risk factor for impaired QoL and poor long-term functional outcomes following spinal surgery, [31] [32] [33] they have not been objectively evaluated as a risk factor for poor outcomes following coccygectomy. In our subset analysis, patients with poor outcomes following coccygectomy had a higher incidence of psychiatric disorders pre-operatively. However, patients with poor outcomes also had worse QoL features, a higher incidence of multiple comorbid diseases, higher VAS pain scores and a higher incidence of opiate use, preoperatively. Indeed, many patients in the success group had psychiatric illness and still had satisfactory results. Moreover, patients with many comorbid conditions may have experienced a 'ceiling effect' and had reached a plateau with treatment, which may have limited quantifiable changes in outcome measures assessing improvement in function and QoL. Therefore, we cannot definitively conclude that specific pre-operative characteristics are related to poorer outcomes following coccygectomy. It is more likely that pain and musculoskeletal impairment in these patients is multifactorial and may not improve significantly with surgery for one condition. Indeed, 19 out of 25 of our patients who did not meet the MCID threshold had some improvement, although not to a level of clinical relevance. Patients with pre-operative characteristics such as psychiatric symptoms or comorbid conditions, or higher pain scores, need to be made aware that they may have less improvement after coccygectomy than a patient without these characteristics. In our series, 11 patients (11.2%) had Most were wound problems that resolved with antibiotics and local treatment. 6, 9, 10, 21, 35, 36 This study is a prospective analysis of a large series of patients treated by a single surgeon with extensive experience with the procedure. It reinforces the argument that patients with chronic coccydynia can benefit from surgical intervention. A weakness of this study is the lack of a nonoperative comparison group. More than 90% of patients in this study had symptoms for more than one year and more than 71% had already failed injection therapy. Although we cannot predict that our patients would not have improved with continued non-operative care, the duration and severity of their symptoms made inclusion in the surgical study appropriate.
In conclusion, coccygectomy is a moderately successful form of treatment for patients with chronic coccydynia. The risks of wound healing complications are substantial, but these risks do not appear to affect the ultimate outcome. As part of the informed consent process, patients should be told of the risk of these complications and the potentially poorer outcomes with certain comorbidities, but that most will achieve a satisfactory outcome. 
